Javelin Pharmaceuticals, INC
SEC CIK 50710 · JVPH:OB · last insider filing 2010-07-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Watson Douglas G | Director | filed 2006 - 2010 |
| Flanzraich Neil | Director | filed 2006 - 2010 |
| Clegg Jackie M | Director | filed 2006 - 2010 |
| Mermelstein Fred H | Director · President & Secretary | filed 2006 - 2010 |
| Carr Daniel B | Director · See Remarks | filed 2006 - 2010 |
| Driscoll Martin J | Director · Chief Executive Officer | filed 2006 - 2010 |
| Nebgen Georg | Director | filed 2006 - 2010 |
| Kiernan Peter D. III | Director | filed 2008 - 2010 |
| Jacobs Joseph | Director | filed 2008 - 2008 |
| Kash Peter M | Director | filed 2006 - 2006 |
| Peters William P | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tulipano Stephen J | Chief Financial Officer | filed 2006 - 2010 |
| Bernstein David B | See Remarks | filed 2006 - 2009 |
| Matthews Mark | VP of Commercial Affairs | filed 2006 - 2007 |
| Hamilton Douglas A | Chief Financial Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.